Patents by Inventor Jasper DE BOER

Jasper DE BOER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer therapy
    Patent number: 11071720
    Abstract: The present invention relates to the treatment of mixed lineage leukemia. In particular, the present invention relates to therapies involving the induction of proteolysis of the MLL fusion proteins that result from the chromosomal translocations affecting the MLL gene at 11q23.
    Type: Grant
    Filed: November 2, 2017
    Date of Patent: July 27, 2021
    Assignee: UCL BUSINESS LTD
    Inventors: Jasper De Boer, Sandra Cantilena
  • CANCER THERAPY
    Publication number: 20190274976
    Abstract: The present invention relates to the treatment of mixed lineage leukemia. In particular, the present invention relates to therapies involving the induction of proteolysis of the MLL fusion proteins that result from the chromosomal translocations affecting the MLL gene at 11q23.
    Type: Application
    Filed: November 2, 2017
    Publication date: September 12, 2019
    Inventors: Jasper DE BOER, Sandra CANTILENA